0010B |
2-fluoro Deschloroketamine and Deschloroketamine (Qualitative), Blood |
0010SP |
2-fluoro Deschloroketamine and Deschloroketamine (Qualitative), Serum/Plasma |
0010U |
2-fluoro Deschloroketamine and Deschloroketamine (Qualitative), Urine |
0014B |
3-MeO-PCP and 3-hydroxy-PCP (Qualitative), Blood |
0014SP |
3-MeO-PCP and 3-hydroxy-PCP (Qualitative), Serum/Plasma |
0014U |
3-MeO-PCP and 3-hydroxy-PCP (Qualitative), Urine |
0015B |
2-methyl AP-237 & AP-238, Blood |
0015SP |
2-methyl AP-237 & AP-238, Serum/Plasma |
0015U |
2-methyl AP-237 & AP-238, Urine |
0080B |
Acetone, Blood |
0080FL |
Acetone, Fluid |
0080SP |
Acetone, Serum/Plasma |
0080U |
Acetone, Urine |
0205B |
Acetyl Fentanyl, Blood |
0205SP |
Acetyl Fentanyl, Serum/Plasma |
0205U |
Acetyl Fentanyl and Metabolite, Urine |
0570B |
Designer Benzodiazepines, Blood |
0570SP |
Designer Benzodiazepines, Serum/Plasma |
0570U |
Designer Benzodiazepines (Qualitative), Urine |
0771B |
Brorphine, Blood |
0771SP |
Brorphine, Serum/Plasma |
0771U |
Brorphine, Urine |
1021B |
Substituted Cathinone Panel, Blood |
1021SP |
Substituted Cathinone Panel, Serum/Plasma |
1021U |
Substituted Cathinone Panel, Urine |
1022B |
Eutylone, Blood |
1022SP |
Eutylone, Serum/Plasma |
1022U |
Eutylone (Qualitative), Urine |
1038B |
Ethylene Glycol Monobutyl Ether, Blood |
1038SP |
Ethylene Glycol Monobutyl Ether, Serum/Plasma |
1039B |
Ethylene Glycol Monoethyl Ether, Blood |
1039SP |
Ethylene Glycol Monoethyl Ether, Serum/Plasma |
1407B |
Cyclohexane, Blood |
1409B |
Cyclohexanone, Blood |
1409SP |
Cyclohexanone, Serum/Plasma |
1409U |
Cyclohexanone, Urine |
1410U |
Cyclohexanol, Urine |
1480B |
Designer Opioids, Blood |
1480SP |
Designer Opioids, Serum/Plasma |
1480U |
Designer Opioids (Qualitative), Urine |
1483B |
Desalkylgidazepam, Blood |
1483SP |
Desalkylgidazepam, Serum/Plasma |
1483U |
Desalkylgidazepam (Qualitative), Urine |
1546B |
Dichlorobenzenes, Blood |
1546SP |
Dichlorobenzenes, Serum/Plasma |
1550B |
Dichloroethane, Blood |
1560B |
Dichloromethane and Carboxyhemoglobin, Blood |
1561B |
Dichloromethane, Blood |
1561U |
Dichloromethane, Urine |
1690B |
Dimethylsulfoxide, Blood |
1690SP |
Dimethylsulfoxide, Serum/Plasma |
1690U |
Dimethylsulfoxide, Urine |
2055B |
Ethylene Glycol Overexposure Profile, Blood |
2055SP |
Ethylene Glycol Overexposure Profile, Serum/Plasma |
2062B |
Ethylene Glycol, Blood |
2062FL |
Ethylene Glycol, Fluid |
2062SP |
Ethylene Glycol, Serum/Plasma |
2062TI |
Ethylene Glycol, Tissue |
2062U |
Ethylene Glycol, Urine |
2165B |
Glycols Panel, Blood |
2165FL |
Glycols Panel, Fluid |
2165LI |
Glycols Panel, Liquid |
2165SP |
Glycols Panel, Serum/Plasma |
2165TI |
Glycols Panel, Tissue |
2165U |
Glycols Panel, Urine |
2270B |
Heptane, n-, Blood |
2270SP |
Heptane, n-, Serum/Plasma |
2290B |
Hexane, n-, Blood |
2290SP |
Hexane, n-, Serum/Plasma |
2292U |
n-Hexane Exposure Monitoring, Urine |
2626B |
Bath Salts Panel (Qualitative), Blood |
2626SP |
Bath Salts Panel (Qualitative), Serum/Plasma |
2626U |
Bath Salts Panel (Qualitative), Urine |
2980B |
Methyl n-Butyl Ketone, Blood |
2984U |
Methyl n-Butyl Ketone Exposure Monitoring, Urine |
3060U |
N,N-Dimethylacetamide Exposure (N-Methylacetamide), Urine |
3064B |
Mitragynine, Blood |
3064SP |
Mitragynine, Serum/Plasma |
3070U |
N,N-Dimethylformamide (DMF) Exposure (N-Monomethylformamide), Urine |
3078U |
Mitragynine (Qualitative), Urine |
3080U |
MOCA, Urine |
3081U |
MOCA and MDA Exposure Profile, Urine |
3098U |
Mono-n-butyl phthalate (MNBP), Urine |
3168B |
Nitazenes Panel, Blood |
3218B |
N,N-Dimethylpentylone & Pentylone, Blood |
3218SP |
N,N-Dimethylpentylone & Pentylone, Serum/Plasma |
3218U |
N,N-Dimethylpentylone & Pentylone, Urine |
3224B |
NPS Stimulants (Qualitative), Blood |
3224SP |
NPS Stimulants (Qualitative), Serum/Plasma |
3224U |
NPS Stimulants (Qualitative), Urine |
4030B |
Pyridine, Blood |
4030SP |
Pyridine, Serum/Plasma |
4030U |
Pyridine, Urine |
4047B |
Pyrrolidinophenone Panel, Blood |
4047SP |
Pyrrolidinophenone Panel, Serum/Plasma |
4282SP |
Synthetic Cannabinoids (Qualitative), Serum/Plasma |
4283U |
Synthetic Cannabinoid Metabolites-Expanded (Qualitative), Urine |
4355B |
Tetrahydrofuran, Blood |
4355SP |
Tetrahydrofuran, Serum/Plasma |
4355U |
Tetrahydrofuran, Urine |
4510B |
Toluene, Blood |
4513U |
Toluene Exposure, Urine |
8054B |
NMS TotalTox™ Panel, Blood (Forensic) Overview: Forensic Analysis; Exclusion Screen; This test is New York State approved. |
8756B |
Novel Psychoactive Substances (NPS) Screen 1, Blood |
8756SP |
Novel Psychoactive Substances (NPS) Screen 1, Serum/Plasma |
8756U |
Novel Psychoactive Substances (NPS) Screen 1, Urine |
9105B |
Acetyl Fentanyl Screen, Blood |
9105SP |
Acetyl Fentanyl Screen, Serum/Plasma |
9105U |
Acetyl Fentanyl Screen, Urine |
9560B |
Synthetic Cannabinoids Screen, Blood |
9562U |
Synthetic Cannabinoid Metabolites Screen - Expanded, Urine |